Vivos Therapeutics, Inc. Notes Payable, Current
Vivos Therapeutics, Inc. (VVOS) had Notes Payable, Current of $7.56 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Notes Payable, Current $7.56M.
- 2026-03-31: Notes Payable, Current $7.10M.
- 2025-12-31: Notes Payable, Current $8.10M.
- 2025-09-30: Notes Payable, Current $7.89M.
| Period end | Notes Payable, Current |
|---|---|
| 2026-06-30 | $7.56M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $7.10M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $8.10M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $7.89M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $7.50M 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |